HEADER HYDROLASE/INHIBITOR 28-OCT-19 6USX TITLE IDENTIFICATION OF THE CLINICAL DEVELOPMENT CANDIDATE MRTX849, A TITLE 2 COVALENT KRASG12C INHIBITOR FOR THE TREATMENT OF CANCER COMPND MOL_ID: 1; COMPND 2 MOLECULE: GTPASE KRAS; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: K-RAS 2,KI-RAS,C-K-RAS,C-KI-RAS; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KRAS, KRAS2, RASK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE INHIBITOR, HYDROLASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.P.VIGERS,D.J.SMITH REVDAT 3 11-OCT-23 6USX 1 LINK REVDAT 2 22-JUL-20 6USX 1 JRNL REVDAT 1 22-APR-20 6USX 0 JRNL AUTH J.B.FELL,J.P.FISCHER,B.R.BAER,J.F.BLAKE,K.BOUHANA, JRNL AUTH 2 D.M.BRIERE,K.D.BROWN,L.E.BURGESS,A.C.BURNS,M.R.BURKARD, JRNL AUTH 3 H.CHIANG,M.J.CHICARELLI,A.W.COOK,J.J.GAUDINO,J.HALLIN, JRNL AUTH 4 L.HANSON,D.P.HARTLEY,E.J.HICKEN,G.P.HINGORANI,R.J.HINKLIN, JRNL AUTH 5 M.J.MEJIA,P.OLSON,J.N.OTTEN,S.P.RHODES,M.E.RODRIGUEZ, JRNL AUTH 6 P.SAVECHENKOV,D.J.SMITH,N.SUDHAKAR,F.X.SULLIVAN,T.P.TANG, JRNL AUTH 7 G.P.VIGERS,L.WOLLENBERG,J.G.CHRISTENSEN,M.A.MARX JRNL TITL IDENTIFICATION OF THE CLINICAL DEVELOPMENT CANDIDATEMRTX849, JRNL TITL 2 A COVALENT KRASG12CINHIBITOR FOR THE TREATMENT OF CANCER. JRNL REF J.MED.CHEM. V. 63 6679 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32250617 JRNL DOI 10.1021/ACS.JMEDCHEM.9B02052 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0253 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 87.3 REMARK 3 NUMBER OF REFLECTIONS : 18040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.432 REMARK 3 FREE R VALUE TEST SET COUNT : 980 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 890 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.19 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2685 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.26600 REMARK 3 B22 (A**2) : -0.48400 REMARK 3 B33 (A**2) : 3.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.329 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.249 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.159 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.423 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2875 ; 0.011 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2555 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3895 ; 1.945 ; 1.725 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5928 ; 1.340 ; 1.597 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 334 ; 6.882 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 157 ;36.579 ;22.611 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 500 ;15.048 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;16.032 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 369 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3154 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 578 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 520 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 38 ; 0.211 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1348 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 108 ; 0.159 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.077 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1342 ; 4.557 ; 4.713 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1341 ; 4.558 ; 4.711 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1674 ; 5.592 ; 7.040 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1675 ; 5.591 ; 7.043 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1533 ; 5.411 ; 5.134 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1439 ; 5.450 ; 5.206 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2221 ; 7.490 ; 7.498 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2087 ; 7.624 ; 7.591 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 6USX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1000245174. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL MIRRORS REMARK 200 OPTICS : OSMIC CONFOCAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32164 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.7 REMARK 200 DATA REDUNDANCY : 3.650 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4L8G.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 29% PEG8K 0.1M NACITRATE PH 5.4 0.2M REMARK 280 AMM ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.28500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 78.24500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.28500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 78.24500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.28500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 78.24500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.28500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 78.24500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLU A 168 REMARK 465 LYS A 169 REMARK 465 LYS B 169 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 49 HH21 ARG A 164 1.54 REMARK 500 CB ASP B 154 O HOH B 329 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 117 32.04 76.68 REMARK 500 SER A 122 39.92 76.50 REMARK 500 ASP B 33 109.15 -33.62 REMARK 500 ALA B 59 -159.32 -171.74 REMARK 500 SER B 122 34.42 -79.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 17 OG REMARK 620 2 GDP A 201 O2B 90.0 REMARK 620 3 HOH A 304 O 92.3 177.0 REMARK 620 4 HOH A 307 O 80.5 86.0 92.4 REMARK 620 5 HOH A 309 O 98.8 83.5 98.0 169.5 REMARK 620 6 HOH A 319 O 166.6 90.6 86.7 86.3 94.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 17 OG REMARK 620 2 GDP B 201 O2B 94.1 REMARK 620 3 HOH B 303 O 170.1 76.0 REMARK 620 4 HOH B 306 O 92.4 86.9 87.7 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GDP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M1R A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GDP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide M1R B 203 and CYS B REMARK 800 12 DBREF 6USX A 1 169 UNP P01116 RASK_HUMAN 1 169 DBREF 6USX B 1 169 UNP P01116 RASK_HUMAN 1 169 SEQADV 6USX GLY A 0 UNP P01116 EXPRESSION TAG SEQADV 6USX CYS A 12 UNP P01116 GLY 12 VARIANT SEQADV 6USX SER A 51 UNP P01116 CYS 51 ENGINEERED MUTATION SEQADV 6USX LEU A 80 UNP P01116 CYS 80 ENGINEERED MUTATION SEQADV 6USX SER A 118 UNP P01116 CYS 118 ENGINEERED MUTATION SEQADV 6USX GLY B 0 UNP P01116 EXPRESSION TAG SEQADV 6USX CYS B 12 UNP P01116 GLY 12 VARIANT SEQADV 6USX SER B 51 UNP P01116 CYS 51 ENGINEERED MUTATION SEQADV 6USX LEU B 80 UNP P01116 CYS 80 ENGINEERED MUTATION SEQADV 6USX SER B 118 UNP P01116 CYS 118 ENGINEERED MUTATION SEQRES 1 A 170 GLY MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA CYS SEQRES 2 A 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 A 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 A 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR SER SEQRES 5 A 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 A 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 A 170 PHE LEU LEU VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 A 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 A 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 A 170 LYS SER ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 A 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 A 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 A 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 A 170 LYS SEQRES 1 B 170 GLY MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA CYS SEQRES 2 B 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 B 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 B 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR SER SEQRES 5 B 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 B 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 B 170 PHE LEU LEU VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 B 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 B 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 B 170 LYS SER ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 B 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 B 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 B 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 B 170 LYS HET GDP A 201 40 HET MG A 202 1 HET M1R A 203 38 HET GDP B 201 40 HET MG B 202 1 HET M1R B 203 38 HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM MG MAGNESIUM ION HETNAM M1R 1-{4-[2-{[(2S)-1-METHYLPYRROLIDIN-2-YL]METHOXY}-7- HETNAM 2 M1R (NAPHTHALEN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[3,4- HETNAM 3 M1R D]PYRIMIDIN-4-YL]PIPERAZIN-1-YL}PROPAN-1-ONE FORMUL 3 GDP 2(C10 H15 N5 O11 P2) FORMUL 4 MG 2(MG 2+) FORMUL 5 M1R 2(C30 H38 N6 O2) FORMUL 9 HOH *75(H2 O) HELIX 1 AA1 GLY A 15 ASN A 26 1 12 HELIX 2 AA2 SER A 65 THR A 74 1 10 HELIX 3 AA3 ASN A 86 ASP A 92 1 7 HELIX 4 AA4 ASP A 92 ASP A 105 1 14 HELIX 5 AA5 ASP A 126 TYR A 137 1 12 HELIX 6 AA6 GLY A 151 LYS A 167 1 17 HELIX 7 AA7 GLY B 15 ASN B 26 1 12 HELIX 8 AA8 SER B 65 ARG B 73 1 9 HELIX 9 AA9 ASN B 86 ASP B 92 1 7 HELIX 10 AB1 ASP B 92 ASP B 105 1 14 HELIX 11 AB2 ASP B 126 GLY B 138 1 13 HELIX 12 AB3 GLY B 151 GLU B 168 1 18 SHEET 1 AA1 6 ASP A 38 ILE A 46 0 SHEET 2 AA1 6 GLU A 49 ASP A 57 -1 O ILE A 55 N TYR A 40 SHEET 3 AA1 6 GLU A 3 VAL A 9 1 N TYR A 4 O ASP A 54 SHEET 4 AA1 6 GLY A 77 ALA A 83 1 O LEU A 79 N VAL A 9 SHEET 5 AA1 6 MET A 111 ASN A 116 1 O ASN A 116 N PHE A 82 SHEET 6 AA1 6 PHE A 141 GLU A 143 1 O ILE A 142 N LEU A 113 SHEET 1 AA2 6 ASP B 38 ILE B 46 0 SHEET 2 AA2 6 GLU B 49 ASP B 57 -1 O ASP B 57 N ASP B 38 SHEET 3 AA2 6 GLU B 3 VAL B 9 1 N TYR B 4 O ASP B 54 SHEET 4 AA2 6 GLY B 77 ALA B 83 1 O LEU B 79 N VAL B 9 SHEET 5 AA2 6 MET B 111 ASN B 116 1 O VAL B 112 N LEU B 80 SHEET 6 AA2 6 PHE B 141 GLU B 143 1 O ILE B 142 N LEU B 113 LINK SG CYS A 12 C32 M1R A 203 1555 1555 1.65 LINK SG CYS B 12 C32 M1R B 203 1555 1555 1.66 LINK OG SER A 17 MG MG A 202 1555 1555 2.09 LINK O2B GDP A 201 MG MG A 202 1555 1555 2.13 LINK MG MG A 202 O HOH A 304 1555 1555 2.21 LINK MG MG A 202 O HOH A 307 1555 1555 2.28 LINK MG MG A 202 O HOH A 309 1555 1555 1.88 LINK MG MG A 202 O HOH A 319 1555 1555 2.05 LINK OG SER B 17 MG MG B 202 1555 1555 2.07 LINK O2B GDP B 201 MG MG B 202 1555 1555 2.13 LINK MG MG B 202 O HOH B 303 1555 1555 2.43 LINK MG MG B 202 O HOH B 306 1555 1555 1.97 SITE 1 AC1 25 ALA A 11 GLY A 13 VAL A 14 GLY A 15 SITE 2 AC1 25 LYS A 16 SER A 17 ALA A 18 PHE A 28 SITE 3 AC1 25 VAL A 29 ASP A 30 GLU A 31 ASN A 116 SITE 4 AC1 25 LYS A 117 ASP A 119 SER A 145 ALA A 146 SITE 5 AC1 25 MG A 202 HOH A 305 HOH A 307 HOH A 309 SITE 6 AC1 25 HOH A 314 HOH A 319 HOH A 326 HOH A 327 SITE 7 AC1 25 HOH A 335 SITE 1 AC2 6 SER A 17 GDP A 201 HOH A 304 HOH A 307 SITE 2 AC2 6 HOH A 309 HOH A 319 SITE 1 AC3 20 CYS A 12 LYS A 16 PRO A 34 THR A 58 SITE 2 AC3 20 ALA A 59 GLY A 60 GLU A 62 GLU A 63 SITE 3 AC3 20 TYR A 64 ARG A 68 ASP A 69 MET A 72 SITE 4 AC3 20 HIS A 95 TYR A 96 GLN A 99 ILE A 100 SITE 5 AC3 20 VAL A 103 HOH A 319 GLN B 61 TYR B 64 SITE 1 AC4 23 GLY B 13 VAL B 14 GLY B 15 LYS B 16 SITE 2 AC4 23 SER B 17 ALA B 18 PHE B 28 VAL B 29 SITE 3 AC4 23 ASP B 30 TYR B 32 ASN B 116 LYS B 117 SITE 4 AC4 23 ASP B 119 LEU B 120 SER B 145 ALA B 146 SITE 5 AC4 23 LYS B 147 MG B 202 M1R B 203 HOH B 303 SITE 6 AC4 23 HOH B 306 HOH B 316 HOH B 319 SITE 1 AC5 4 SER B 17 GDP B 201 HOH B 303 HOH B 306 SITE 1 AC6 21 CYS A 12 ALA B 11 GLY B 13 VAL B 14 SITE 2 AC6 21 LYS B 16 PRO B 34 ALA B 59 GLY B 60 SITE 3 AC6 21 GLU B 62 GLU B 63 TYR B 64 ARG B 68 SITE 4 AC6 21 ASP B 69 MET B 72 HIS B 95 TYR B 96 SITE 5 AC6 21 GLN B 99 ILE B 100 GDP B 201 HOH B 303 SITE 6 AC6 21 HOH B 331 CRYST1 88.570 156.490 62.980 90.00 90.00 90.00 C 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011291 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006390 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015878 0.00000